FDA Will Review Safety Of Dental Amalgams In Light Of New Data
This article was originally published in The Gray Sheet
Executive Summary
CDRH is willing to do some more number-crunching on its 2009 decision that mercury from dental amalgam is safe for all patients, in light of new data that most of the U.S. population may be exposed to higher levels of the toxin in their fillings than is acceptable, FDA officials said at a recent advisory panel meeting.
You may also be interested in...
FDA Advisory Panel Debates Science On Human Adverse Biological Reactions To Metal-Containing Devices
US FDA scientists and immunological experts discussed the latest science regarding patients’ biological reactions to metal implants and mercury in dental amalgam at a 13-14 November agency advisory committee meeting. The get-together was held to determine what additional actions the FDA can take to make sure certain patients are protected from immunological risks of the implants. The panel ultimately backed a transition away from mercury amalgam dental fillings and pushed for more research into risks associated with metal implants.
Regulatory News In Brief
Stolen Boston Scientific devices
Regulatory News In Brief
Stolen Boston Scientific devices